All news

Wells Fargo lifts Elevance target to $492 on Medicaid

Alpha Vantage · Investing.com · · AI-summarised by FinFlash

Wells Fargo raised its Elevance Health price target to $492 from $473, keeping an Overweight rating after strong third-quarter results driven by Medicaid and health insurance exchange performance. The firm's 2026 EPS estimate of $30.28 sits 4.5% above consensus, with solid growth expected through 2028. Bernstein, BofA Securities and Guggenheim also lifted targets after the earnings beat and raised outlook.

Read original source

ELV company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.